Eyevensys is a private clinical stage biotechnology company that is developing a novel approach for treating ocular diseases.
Our mission is to address critical unmet ophthalmic needs using our first-in-class non-viral gene therapy sustained delivery platform to overcome the limitations of current treatment options—including intravitreal injections, surgery, intravitreal implants and biodegradable formulations.
